Get the Stockscreener App
2.09
0.48%
0.010
After Hours:
2.05
-0.04
-1.91%
Ispecimen Inc stock is traded at $2.09, with a volume of 77,470.
It is up +0.48% in the last 24 hours and down -25.36% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$2.08
Open:
$2.1
24h Volume:
77,470
Relative Volume:
0.13
Market Cap:
$2.01M
Revenue:
$10.39M
Net Income/Loss:
$-9.52M
P/E Ratio:
-0.1093
EPS:
-19.12
Net Cash Flow:
$-6.02M
1W Performance:
+1.46%
1M Performance:
-25.36%
6M Performance:
-61.44%
1Y Performance:
-77.13%
1-Day Range:
$2.01
$2.132
1-Week Range:
$2.00
$2.1773
52-Week Range:
$1.96
$11.80
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
2.09 | 2.01M | 10.39M | -9.52M | -6.02M | -19.12 |
|
TMO
Thermo Fisher Scientific Inc
|
606.74 | 232.08B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
223.08 | 160.42B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
151.38 | 42.01B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.78 | 36.62B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
423.99 | 34.72B | 3.84B | 866.24M | 792.60M | 10.37 |
Ispecimen Inc Stock (ISPC) Latest News
Certain Warrants of iSpecimen Inc. are subject to a Lock-Up Agreement Ending on 30-JAN-2025. - Marketscreener.com
iSpecimen Stock Hits 52-Week Low at $2.25 Amid Market Challenges - Investing.com
The Secret to Sustainable Healthcare Innovation. Discover How Emerging Tech is Changing the Game. - MotoPaddock
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
US Stock Likely To Open Higher Ahead of Trump's Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst - Benzinga
US Stocks Likely To Open Higher Ahead of Trump's Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst - Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Benzinga
Stock Region Penny Picks - substack.com
iSpecimen Shares Rise After Securring Virus Suppliers - MarketWatch
ISpecimen Secures Suppliers for COVID-style hMPV Outbreak -January 16, 2025 at 04:02 pm EST - Marketscreener.com
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak - Newsfile
ISPC Stock: The Next Tech Breakthrough? Discover the Future of Investing! - MotoPaddock
Waters Corporation (WAT) Stock Surges Amid Strong Financial Perf - GuruFocus.com
iSpecimen stock hits 52-week low at $2.6 amid market challenges - Investing.com
Scientists just excavated an unprecedented specimen from Antarctica - Mashable
AWH Stock Surges Over 5% Amid Mixed Analyst Ratings - GuruFocus.com
iSpecimen Inc. (NASDAQ:ISPC) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough - Simply Wall St
ISpecimen Inc. Appoints Yuying Liang as Chief Financial Officer - Marketscreener.com
ISpecimen Will Serve as a Preferred Provider of Cancer Biospecimens - Marketscreener.com
iSpecimen stock hits 52-week low at $2.75 amid market challenges - Investing.com
iSpecimen Strengthens Leadership and Expands Cancer Research Focus - TipRanks
iSpecimen expands cancer biospecimen services for research - Investing.com
iSpecimen Unveils Major Cancer Biospecimen Initiative, Partners with Leading Genomics Lab for 2025 Growth - StockTitan
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens - Newsfile
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
ISpecimen Inc. Appoints Robert Bradley Lim as Chief Executive Officer - Marketscreener.com
ISpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers - Marketscreener.com
Cal-Maine Foods IN (CALM-Q) QuotePress Release - The Globe and Mail
iSpecimen appoints Robert Lim as CEO - MSN
Pre-market Movers: LOOP, RPTX, CADL, INO, ISPC… - RTTNews
iSpecimen's Next Day Quote Program Drives 60% of Purchase Orders, Revolutionizing Biospecimen Sales - StockTitan
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers - Newsfile
iSpecimen Appoints Robert Lim as New CEO - TipRanks
iSpecimen Appoints Robert Lim as CEO and Director - Newsfile
ISpecimen : Appoints Robert Lim as CEO and Director Form 8 K - Marketscreener.com
iSpecimen stock hits 52-week low at $3.4 amid market challenges By Investing.com - Investing.com South Africa
iSpecimen stock hits 52-week low at $3.4 amid market challenges - Investing.com
The Beautiful Ludlow Typography Specimen Books c. 1958 - Flashbak
This Micro-Cap Stock Deserves a Second Look - RagingBull
ISpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - Marketscreener.com
Bernstein: 'Welcome to the crypto bull marketBuy everything you can' - Investing.com
iSpecimen Inc. Reports Earnings Amid Financial Challenges - TipRanks
iSpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - The Globe and Mail
iSpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - The Globe and Mail
E.L.F. Beauty Inc (ELF-N) QuotePress Release - The Globe and Mail
ISpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - Marketscreener.com
iSpecimen Inc. Stocks 48% Premarket Surge On Thursday Ignited A Regular Session Rally - The Globe and Mail
iSpecimen Emerges as Key Player in $13.5B Biospecimen Market, Shows 13.3% Growth Potential | ISPC Stock News - StockTitan
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually - The Manila Times
iSpecimen Expands Cancer Sample Database, Projects $10M Annual Orders & 20% Growth | ISPC Stock News - StockTitan
iSpecimen Reports Third Quarter 2024 Results - The Manila Times
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):